Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA.
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Nat Neurosci. 2020 Apr;23(4):510-519. doi: 10.1038/s41593-020-0604-z. Epub 2020 Mar 16.
Specific cell populations may have unique contributions to schizophrenia but may be missed in studies of homogenate tissue. Here laser capture microdissection followed by RNA sequencing (LCM-seq) was used to transcriptomically profile the granule cell layer of the dentate gyrus (DG-GCL) in human hippocampus and contrast these data to those obtained from bulk hippocampal homogenate. We identified widespread cell-type-enriched aging and genetic effects in the DG-GCL that were either absent or directionally discordant in bulk hippocampus data. Of the ~9 million expression quantitative trait loci identified in the DG-GCL, 15% were not detected in bulk hippocampus, including 15 schizophrenia risk variants. We created transcriptome-wide association study genetic weights from the DG-GCL, which identified many schizophrenia-associated genetic signals not found in transcriptome-wide association studies from bulk hippocampus, including GRM3 and CACNA1C. These results highlight the improved biological resolution provided by targeted sampling strategies like LCM and complement homogenate and single-nucleus approaches in human brain.
特定的细胞群体可能对精神分裂症有独特的贡献,但在匀浆组织的研究中可能会被忽略。在这里,我们使用激光捕获显微切割和 RNA 测序(LCM-seq)技术对人海马体齿状回颗粒细胞层(DG-GCL)进行转录组分析,并将这些数据与从海马体匀浆获得的数据进行对比。我们发现,DG-GCL 中存在广泛的细胞类型特异性的衰老和遗传效应,而这些效应在海马体匀浆数据中要么不存在,要么方向不一致。在 DG-GCL 中鉴定出的约 900 万个表达数量性状基因座中,有 15%在海马体匀浆中未被检测到,其中包括 15 个精神分裂症风险变异。我们从 DG-GCL 中创建了全转录组关联研究遗传权重,这些权重确定了许多在从海马体匀浆进行的全转录组关联研究中未发现的与精神分裂症相关的遗传信号,包括 GRM3 和 CACNA1C。这些结果突出了靶向采样策略(如 LCM)提供的更高的生物学分辨率,与人类大脑中的匀浆和单核细胞方法互补。
Transl Psychiatry. 2014-3-4
Transl Psychiatry. 2015-4-14
Genome Med. 2017-7-28
Am J Hum Genet. 2021-9-2
Neuropsychopharmacology. 2013-1-7
medRxiv. 2025-7-14
Genomics Proteomics Bioinformatics. 2024-12-3
Nature. 2019-5-1
Neuropsychopharmacol Rep. 2018-12